F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response
NCT00180193 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2009-08-26
Summary
The purpose of this study is to monitor the amino acid uptake of brain tumors, before and during radiotherapy, with positron emission tomography.
Conditions
Sponsors & Collaborators
-
Advanced Biochemical Compounds GmbH
collaborator INDUSTRY -
Technische Universität Dresden
lead OTHER
Principal Investigators
-
Joerg Kotzerke, MD · Department of Nuclear Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-12-31
Countries
- Germany
Study Locations
More Related Trials
-
FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer
NCT01432002 ·Status: UNKNOWN
-
Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer
NCT00826033 ·Status: COMPLETED
-
A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas
NCT02104310 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Brain Metastases Treated With Stereotactic Radiotherapy Using Dynamic [18F]FDG PET
NCT06511323 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
NCT01260480 ·Status: UNKNOWN ·Phase: PHASE2
-
Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5
NCT00743353 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Feasibility Study on the Use of F-18-FDG-PET and Optical Imaging in Evaluation of Radiation-induced Oral Mucositis
NCT01077869 ·Status: TERMINATED
-
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
NCT02717572 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
NCT00805636 ·Status: UNKNOWN ·Phase: PHASE2
-
PET and MRI Imaging of Brain Tumors Using [18F]PARPi
NCT04173104 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Implications of Biological and Procedural Factors of 18-f FDG Uptake by Normal Organs and Neoplastic Lesions
NCT06626932 ·Status: NOT_YET_RECRUITING
-
[F-18]Fluoro-DOPA PET Imaging of Brain Tumors in Children
NCT00556153 ·Status: WITHDRAWN
-
Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4
NCT04017819 ·Status: SUSPENDED ·Phase: PHASE1
-
Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma
NCT06795113 ·Status: RECRUITING
-
18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain
NCT04462419 ·Status: TERMINATED
-
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
NCT01421953 ·Status: COMPLETED ·Phase: NA
-
Dynamic F-DOPA PET for Differential Diagnosis Between Recurrence and Radionecrosis of Brain Metastasis
NCT05762172 ·Status: COMPLETED ·Phase: NA
-
PD-L1 PET Imaging in Melanoma Patients
NCT03520634 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)
NCT00959582 ·Status: COMPLETED ·Phase: PHASE1
-
Tracer Targeting FAP PET Imaging in Patients
NCT05691894 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
NCT00707343 ·Status: COMPLETED ·Phase: PHASE1
-
18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors
NCT04258592 ·Status: TERMINATED ·Phase: PHASE1
-
Clinical Study of 18F-FAPI-RGD in Ovarian Cancer
NCT06614062 ·Status: COMPLETED
-
PET/CT-Assessment of Liver Tumor Ablation
NCT02018107 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00894101 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3